What Is a Medical Case Study and Its Purpose in Science?

A medical case study, more commonly called a case report in clinical literature, is a detailed written account of one patient’s diagnosis, treatment, and outcome, published so that other clinicians and researchers can learn from the experience. It is one of the oldest forms of medical documentation, and despite sitting near the bottom of the formal evidence hierarchy, it serves purposes that larger studies cannot easily replicate: flagging unknown drug side effects, describing diseases so rare that a clinical trial will never be feasible, and generating the hypotheses that bigger research projects go on to test.

What a Case Report Actually Contains

A published case report follows a fairly standardized structure. At minimum, it includes an abstract, an introduction explaining why the case is worth reporting, the case itself, and a discussion that puts the findings in context.¹ The case section is where most of the clinical detail lives. It walks through the patient’s background, their medical history, the results of physical exams and lab tests, what treatment was chosen, what the clinicians expected to happen, and what actually happened. Think of it as a patient’s story told in enough clinical detail that another doctor, halfway around the world, could recognize the same situation if it walked into their office.

A case series is the close cousin. Instead of a single patient, it describes a small group of patients who share something in common, such as the same unusual complication or the same unexpected response to a medication. Both formats are considered descriptive research: they document what happened rather than testing a formal hypothesis the way a randomized trial does.²

How Case Reports Generate Hypotheses

One of the most underrated functions of a case report is its ability to spark entirely new lines of investigation. A clinician notices something unexpected in a single patient, writes it up, and that observation becomes the seed of a research program. A well-known example is Syndrome X, a condition involving chest pain and abnormal heart tracings in patients whose coronary arteries looked perfectly normal. The hypothesis that this syndrome might involve abnormal adenosine receptor activity was originally derived from the careful study of individual cases.³ That kind of creative leap, connecting an unusual observation to a possible mechanism, is something a case report is uniquely positioned to do. Large trials are designed to confirm or reject a hypothesis that already exists. Someone has to come up with the hypothesis first, and case reports are often where that happens.

The Special Role in Rare Diseases

For conditions that affect only a handful of people, a randomized controlled trial is essentially impossible. You cannot recruit thousands of patients for a disease that has been seen in fewer than a hundred people worldwide. Case reports and small case series fill this gap by documenting how the disease presents, how it progresses, and which treatments seem to help.⁴ For rare conditions, published case reports may be the only clinical literature that exists. Clinicians diagnosing a rare disease for the first time often rely on these reports to guide their decisions, because there is simply no higher-level evidence available.

This also applies to unusual presentations of common diseases. A well-known illness showing up in a body system it does not normally affect, or presenting with symptoms that standard textbooks do not mention, is worth documenting even though the disease itself is familiar. These edge-case reports help the broader medical community recognize atypical patterns that might otherwise be missed or misdiagnosed.

Flagging Dangerous Drug Side Effects

Perhaps the most consequential role case reports play is in drug safety surveillance. When a medication reaches the market, it has been tested in controlled trials involving thousands of people, but thousands is still a small fraction of the millions who will eventually take it. Rare side effects, delayed reactions, and dangerous interactions with other drugs often do not show up until the medication is in widespread use. When a doctor observes a patient developing an unexpected and serious problem after starting a new drug, the published case report becomes an early warning signal.

A review of drug withdrawals found that in roughly four out of five cases, the evidence supporting the decision to pull a drug from the market came from individual case reports, case series, or a combination of case reports and clinical trial data.⁵ That is a striking number. It means the safety net that catches dangerous medications after they have already been approved leans heavily on clinicians noticing something wrong and writing it up for their peers. Without case reports, many of these signals would remain isolated observations in individual hospital systems, never aggregated into a pattern that regulators could act on.

The process is not foolproof. A large analysis of published reports of suspected drug-induced liver injury found that when the cases were carefully reassessed, alternative causes turned out to be more likely in about a third of them.⁶ That does not mean the reports were useless. It means case reports are the starting point of an investigation, not the final word. They raise the alarm; larger, more controlled studies confirm or refute it.

Where Case Reports Sit in the Evidence Hierarchy

Evidence-based medicine ranks different types of research by how reliable their conclusions tend to be. Systematic reviews and meta-analyses sit at the top. Randomized controlled trials come next. Observational studies of various designs fill the middle. Case reports and expert opinion occupy the lower rungs.⁷ This ranking exists for good reason: a single patient’s experience cannot tell you what will happen to most patients. But placing case reports low on the hierarchy sometimes leads people to dismiss them entirely, which misses the point. The hierarchy ranks how much confidence you should place in a finding for making treatment decisions across populations. It does not rank how useful a research format is for discovery, education, or safety surveillance.

A formal review of the format’s strengths and weaknesses lays out the major limitations plainly: you cannot generalize from one patient, you cannot prove cause and effect, there is a risk of over-interpreting the findings, and the very fact that unusual cases are more likely to be published creates a built-in selection bias.⁸ Publication bias is worth pausing on: clinicians tend to write up surprising outcomes, not routine ones. A drug that causes a dramatic allergic reaction in one patient will generate a case report. A drug that works exactly as expected in a hundred patients will not. This means the published literature of case reports is skewed toward the unusual by design.

Training the Next Generation of Doctors

Case studies play a major role in medical education, and this extends well beyond reading published case reports. Medical schools routinely use clinical cases as teaching tools. Students are presented with a patient scenario, work through the diagnostic process, and compare their reasoning against the actual outcome. This case-based approach helps students build what educators call illness scripts: mental templates of how a disease typically presents, which they can later match against real patients.

Research on case-based clinical reasoning training found that students who worked through cases developed richer illness scripts and performed better at diagnosis for the diseases they had studied through cases compared to diseases they had not.⁹ A separate randomized trial compared different ways of presenting clinical cases and found that live case discussions produced the strongest learning outcomes, though video-based discussions performed nearly as well on follow-up testing.¹⁰ When students were offered a structured worksheet for analyzing cases instead of the traditional question-and-answer group format, about four out of five preferred the new approach.¹¹

For early-career physicians, writing a case report is also a common entry point into academic publishing. It teaches the discipline of organizing clinical observations, reviewing the relevant literature, and presenting findings clearly. For many residents, a case report is the first thing they publish.

Ethical Obligations and Patient Consent

Publishing detailed clinical information about a real person raises obvious privacy concerns. Even when names are removed, a combination of details, such as age, location, medical history, and the rarity of the condition, can sometimes make a patient identifiable. For this reason, an international standard now calls for written informed consent from any patient who is the subject of a published case report.¹²

In practice, compliance is imperfect. A recent cross-sectional study of published case reports found that while about 79% mentioned obtaining informed consent, only 46% reported involvement of an ethics committee, and the justifications for not seeking ethics approval varied widely.¹³ Part of the inconsistency comes from genuine ambiguity. In many institutions, describing clinical care that was already happening does not meet the regulatory definition of “research,” which means it may not technically require ethics committee review. But whether it requires it or not, the patient still has a stake in whether their medical story is published. The gap between the ethical ideal and actual reporting practice remains a sore spot in the field.

The Push for Better Reporting Standards

One long-standing criticism of case reports is that their quality varies enormously. Two reports describing similar patients might include completely different levels of detail, making it hard to compare them or draw any broader conclusions. To address this, a group of researchers and journal editors developed the CARE (CAse REport) guidelines, a 13-item checklist designed to standardize what a case report should include.¹⁴ The checklist covers things like the patient’s timeline, diagnostic assessment, therapeutic interventions, and follow-up outcomes. Its developers argue that if case reports are written consistently, it becomes possible to aggregate their findings systematically, mining the collective experience of many individual cases rather than treating each one as an isolated anecdote.¹⁵

The CARE guidelines represent a broader shift in thinking about case reports: rather than viewing them as inherently low-value, the goal is to treat them as a data source that becomes more useful when the reports are structured consistently. This is especially relevant as digital tools make it easier to search and analyze large numbers of case reports at once.

From Case Reports to N-of-1 Trials

One natural evolution of the case report is the N-of-1 trial. A traditional case report is observational: the clinician describes what happened. An N-of-1 trial takes a single patient (or a very small number) and applies the rigor of a randomized controlled trial, typically using a crossover design where the patient alternates between the active treatment and a placebo, ideally without knowing which is which. This blinding and randomization dramatically reduce the biases that plague ordinary case reports.¹⁶

N-of-1 trials are particularly useful for conditions where treatment response varies a lot from person to person, and you need to know whether a specific treatment works for a specific individual rather than for the average patient. They are not a replacement for large trials when those are feasible, but they bridge the gap between anecdotal observation and controlled evidence in situations where studying many patients is impractical.

Mining Case Reports with Machine Learning

The sheer volume of case reports published each year creates an opportunity for automated analysis. Researchers have developed machine learning systems that can scan published case reports and extract mentions of potential adverse drug events, essentially creating a scalable tool for drug safety professionals to catch signals buried in thousands of reports written as free text.¹⁷ Other projects have applied text mining to case reports for purposes well beyond pharmacovigilance, including using the clinical descriptions within reports as training data for diagnostic classification algorithms.¹⁸

This computational angle ties directly back to the CARE guidelines. The more consistently case reports are structured, the easier it is for software to pull out the relevant details. A well-formatted report with clear labels for diagnosis, treatment, and outcome can be processed automatically. A report buried in unstructured prose requires much more work to parse. The push for standardization is partly about human readers and partly about making the global archive of case reports machine-readable.

The Patient’s Voice in Case Reporting

Traditionally, case reports are told entirely from the clinician’s point of view. The patient is described, but does not speak. A growing movement advocates for including a patient perspective section, giving the person at the center of the case a chance to describe their experience in their own words. Several reporting guidelines now recommend or encourage this addition.¹⁹

Research on these patient-perspective sections shows that practitioner and patient narratives often configure the same clinical events quite differently. The clinician’s account follows the conventions of clinical reporting: structured, sequential, focused on measurable outcomes. The patient’s account is grounded in lived experience and may emphasize aspects of care the clinician did not think to mention, such as the emotional toll, the experience of uncertainty, or practical disruptions to daily life.²⁰ Including both perspectives enriches the report and reminds readers that behind every case is a person whose experience of their illness does not neatly map onto the clinical timeline.

Publishing Realities and Journal Economics

The landscape for publishing case reports has changed rapidly. Since the launch of the Journal of Medical Case Reports in 2006, the number of journals willing to publish case reports has grown dramatically, and most of these newer venues are open access. Open access means readers do not pay to read the article, but authors typically pay a publication fee. As the number of open-access publishers exploded, so did the number of predatory publishers, outfits that charge fees while providing little or no real peer review.²¹

There is also an uncomfortable truth about how case reports affect a journal’s impact factor, the metric many researchers and institutions use to gauge a journal’s prestige. A bibliometric analysis found that the average case report published in 2015–2016 was cited less than once in 2017, and about 30% were not cited at all. Roughly four out of five case reports were cited less often than you would expect based on their journal’s impact factor, meaning they dragged the metric down slightly.²² This creates a perverse incentive: journals chasing higher impact factors may be reluctant to publish case reports even when the clinical content is valuable. The metric penalizes a format whose primary contribution is often not measured in citations but in early warnings, educational value, and documentation of the unusual.

Case Reports Beyond Human Medicine

The case report format is not limited to human patients. Veterinary medicine relies on the same approach to document unusual diseases, novel surgical techniques, and unexpected treatment responses in animals. Sometimes veterinary and human case reports inform each other directly. A case report documenting Charcot-Leyden crystals in a veterinary context prompted a protein sequence analysis comparing the relevant structure across species. The comparison found that only three nonhuman primate species had a sequence similarity above 80%, suggesting the crystals are essentially unique to humans and their close relatives.²³ That kind of cross-species insight, generated by a single veterinary case report, has implications for understanding human disease biology as well. The format’s flexibility is part of its strength: wherever a clinician encounters something worth documenting, whether the patient walks on two legs or four, the case report provides a vehicle for sharing it.

Legal and Medicolegal Uses

Case reports also surface in contexts most people do not initially associate with medical science. In malpractice litigation, published case reports and case analyses are used to establish what constitutes accepted medical practice. When a court needs to determine whether a physician met the standard of care, documented cases showing how other clinicians handled the same situation become relevant evidence. Published case analyses of malpractice cases have explored legal principles like the patient-physician relationship and how courts determine liability when multiple providers, such as emergency physicians and consulting specialists, are involved in a single patient’s care.²⁴ The case report format, originally designed to share clinical knowledge, ends up serving as a record that courts, regulators, and policymakers draw on when questions of accountability arise.